Clinical trial

Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients

NCT00346697 · Brown, Todd, M.D., Ph.D., Other · Completed

Key facts

NCT number NCT00346697
Title Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
Official title A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy
Lead sponsor Brown, Todd, M.D., Ph.D., Other
Collaborators National Center for Complementary and Integrative Health (NCCIH) NIH GlaxoSmithKline Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions HIV Infections, AIDS, Dyslipidemia, Hypertriglyceridemia
Intervention type Drug
Interventions Omega-3 fatty acid administration, Placebo
Enrollment 48
Start date Oct 1, 2006
Primary completion Apr 1, 2010
Completion Apr 1, 2010
First posted Jun 30, 2006
Last update posted Nov 5, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies